AR016502A1 - Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas. - Google Patents
Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas.Info
- Publication number
- AR016502A1 AR016502A1 ARP990103678A ARP990103678A AR016502A1 AR 016502 A1 AR016502 A1 AR 016502A1 AR P990103678 A ARP990103678 A AR P990103678A AR P990103678 A ARP990103678 A AR P990103678A AR 016502 A1 AR016502 A1 AR 016502A1
- Authority
- AR
- Argentina
- Prior art keywords
- sulfamates
- biogenic
- sulfamate
- replacement therapy
- hormone replacement
- Prior art date
Links
- 230000000035 biogenic effect Effects 0.000 title abstract 3
- 238000002657 hormone replacement therapy Methods 0.000 title abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 2
- 229940011871 estrogen Drugs 0.000 abstract 2
- 239000000262 estrogen Substances 0.000 abstract 2
- 239000000583 progesterone congener Substances 0.000 abstract 2
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 abstract 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 abstract 1
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 abstract 1
- QMBJSIBWORFWQT-DFXBJWIESA-N Chlormadinone acetate Chemical compound C1=C(Cl)C2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 QMBJSIBWORFWQT-DFXBJWIESA-N 0.000 abstract 1
- VGHIBOFCBWMZNZ-ZXXIGWHRSA-N NS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 Chemical compound NS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 VGHIBOFCBWMZNZ-ZXXIGWHRSA-N 0.000 abstract 1
- YXYXCSOJKUAPJI-ZBRFXRBCSA-N [(8r,9s,13s,14s,17s)-17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] sulfamate Chemical compound NS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 YXYXCSOJKUAPJI-ZBRFXRBCSA-N 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 229960001616 chlormadinone acetate Drugs 0.000 abstract 1
- 229960000978 cyproterone acetate Drugs 0.000 abstract 1
- UWFYSQMTEOIJJG-FDTZYFLXSA-N cyproterone acetate Chemical compound C1=C(Cl)C2=CC(=O)[C@@H]3C[C@@H]3[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(C)=O)(OC(=O)C)[C@@]1(C)CC2 UWFYSQMTEOIJJG-FDTZYFLXSA-N 0.000 abstract 1
- 229960004976 desogestrel Drugs 0.000 abstract 1
- RPLCPCMSCLEKRS-BPIQYHPVSA-N desogestrel Chemical compound C1CC[C@@H]2[C@H]3C(=C)C[C@](CC)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 RPLCPCMSCLEKRS-BPIQYHPVSA-N 0.000 abstract 1
- 229960003309 dienogest Drugs 0.000 abstract 1
- AZFLJNIPTRTECV-FUMNGEBKSA-N dienogest Chemical compound C1CC(=O)C=C2CC[C@@H]([C@H]3[C@@](C)([C@](CC3)(O)CC#N)CC3)C3=C21 AZFLJNIPTRTECV-FUMNGEBKSA-N 0.000 abstract 1
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 abstract 1
- 229960004845 drospirenone Drugs 0.000 abstract 1
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 abstract 1
- 229960005309 estradiol Drugs 0.000 abstract 1
- 229930182833 estradiol Natural products 0.000 abstract 1
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 1
- 229960001348 estriol Drugs 0.000 abstract 1
- 229960003399 estrone Drugs 0.000 abstract 1
- -1 estrone sulfamates Chemical class 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 229940053934 norethindrone Drugs 0.000 abstract 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Uso de sulfamatos de estrogenos biogénicos para la administracion oral y discontinua en una terapia de reemplazo de hormonas (HRT). Dosis discontinuas sonadministradas a intervalos de 2 a 40 días. Administracion adicional de gestágenos es también proyectada preferiblemente de manera continua desde un implante oun dispensador intrauterino (IUD). Los sulfamatos de estrogeno biogénico usados son sulfamatos de estrona, sulfamato de estradiol, sulfamato de estriol, o unN-acil sulfamato de esterona, estradiol o estriol conteniendo hasta 7C-átomos en su cadena acílica, o una combinacion de dos o más de dichos ingredientesactivos. Dichos gestágenos son levonogestrel, desogestrel, noretisterona, acetato de ciproterona, acetato de clormadinona, dienogest, drospirenona, o unacombinacion de dos o más de dichos ingredientes activos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19834931A DE19834931A1 (de) | 1998-07-28 | 1998-07-28 | Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016502A1 true AR016502A1 (es) | 2001-07-04 |
Family
ID=7876248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990103678A AR016502A1 (es) | 1998-07-28 | 1999-07-27 | Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7053077B1 (es) |
| EP (1) | EP1100509B1 (es) |
| JP (1) | JP4891479B2 (es) |
| KR (1) | KR20010072082A (es) |
| CN (1) | CN1311683A (es) |
| AP (1) | AP2001002054A0 (es) |
| AR (1) | AR016502A1 (es) |
| AT (1) | ATE292468T1 (es) |
| AU (1) | AU766019B2 (es) |
| BG (1) | BG105171A (es) |
| BR (1) | BR9912466A (es) |
| CA (1) | CA2338558A1 (es) |
| CO (1) | CO5261567A1 (es) |
| DE (2) | DE19834931A1 (es) |
| EA (1) | EA003371B1 (es) |
| EE (1) | EE200100053A (es) |
| HK (1) | HK1040192A1 (es) |
| HU (1) | HUP0102913A3 (es) |
| IL (1) | IL141081A0 (es) |
| IS (1) | IS5819A (es) |
| MX (1) | MXPA01000548A (es) |
| NO (1) | NO20010468L (es) |
| NZ (1) | NZ509521A (es) |
| PL (1) | PL345588A1 (es) |
| SK (1) | SK1292001A3 (es) |
| TR (1) | TR200100234T2 (es) |
| WO (1) | WO2000006175A1 (es) |
| ZA (1) | ZA200100743B (es) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003006027A1 (en) | 2001-07-13 | 2003-01-23 | Schering Aktiengesellschaft | Combination of drospirenone and an estrogen sulphamate for hrt |
| US8026229B2 (en) | 2001-08-13 | 2011-09-27 | Sterix Limited | Antitumor-active 2-alkoxyestradiol sulfamates |
| US8282612B1 (en) | 2008-03-07 | 2012-10-09 | Denise H. Miller | Methods and devices for intrauterine absorption |
| EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP2647379A1 (en) * | 2012-04-05 | 2013-10-09 | PregLem S.A. | Combined use of a steroid sulfatase inhibitor for the treatment of endometriosis |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9078786B1 (en) | 2012-10-19 | 2015-07-14 | Denise H. Miller | Methods and devices for collecting body fluids |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10206932B2 (en) | 2014-05-22 | 2019-02-19 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| CA3020153A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| CN116392450B (zh) * | 2022-09-07 | 2025-07-01 | 江苏集萃新型药物制剂技术研究所有限公司 | 含雌激素的皮下植入物及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314694A (en) * | 1990-10-29 | 1994-05-24 | Alza Corporation | Transdermal formulations, methods and devices |
| EP0708636A1 (en) * | 1993-06-29 | 1996-05-01 | Leiras Oy | Pack for use in, and method of hormonal replacement therapy |
| DE4429397C2 (de) * | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
| DE4429398C2 (de) * | 1994-08-09 | 1997-09-11 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption |
| DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
| DE19610635A1 (de) * | 1996-03-11 | 1997-09-18 | Schering Ag | Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie |
| IL123422A (en) * | 1997-03-05 | 2003-05-29 | Akzo Nobel Nv | USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS |
| WO2000003678A2 (en) * | 1998-07-17 | 2000-01-27 | Pharmacia & Upjohn Company | Subcutaneous medroxyprogesterone acetate for contraception |
-
1998
- 1998-07-28 DE DE19834931A patent/DE19834931A1/de not_active Withdrawn
-
1999
- 1999-05-13 HK HK02101596.4A patent/HK1040192A1/zh unknown
- 1999-05-13 PL PL99345588A patent/PL345588A1/xx unknown
- 1999-05-13 AU AU51481/99A patent/AU766019B2/en not_active Ceased
- 1999-05-13 TR TR2001/00234T patent/TR200100234T2/xx unknown
- 1999-05-13 HU HU0102913A patent/HUP0102913A3/hu unknown
- 1999-05-13 NZ NZ509521A patent/NZ509521A/en unknown
- 1999-05-13 US US09/744,574 patent/US7053077B1/en not_active Expired - Fee Related
- 1999-05-13 CA CA002338558A patent/CA2338558A1/en not_active Abandoned
- 1999-05-13 SK SK129-2001A patent/SK1292001A3/sk unknown
- 1999-05-13 DE DE59911879T patent/DE59911879D1/de not_active Expired - Lifetime
- 1999-05-13 AP APAP/P/2001/002054A patent/AP2001002054A0/en unknown
- 1999-05-13 IL IL14108199A patent/IL141081A0/xx unknown
- 1999-05-13 WO PCT/DE1999/001496 patent/WO2000006175A1/de not_active Ceased
- 1999-05-13 JP JP2000562029A patent/JP4891479B2/ja not_active Expired - Fee Related
- 1999-05-13 EE EEP200100053A patent/EE200100053A/xx unknown
- 1999-05-13 KR KR1020017001165A patent/KR20010072082A/ko not_active Withdrawn
- 1999-05-13 EA EA200100108A patent/EA003371B1/ru not_active IP Right Cessation
- 1999-05-13 AT AT99936276T patent/ATE292468T1/de not_active IP Right Cessation
- 1999-05-13 CN CN99809213A patent/CN1311683A/zh active Pending
- 1999-05-13 EP EP99936276A patent/EP1100509B1/de not_active Expired - Lifetime
- 1999-05-13 MX MXPA01000548A patent/MXPA01000548A/es unknown
- 1999-05-13 BR BR9912466-1A patent/BR9912466A/pt not_active IP Right Cessation
- 1999-07-26 CO CO99046902A patent/CO5261567A1/es not_active Application Discontinuation
- 1999-07-27 AR ARP990103678A patent/AR016502A1/es not_active Application Discontinuation
-
2001
- 2001-01-19 IS IS5819A patent/IS5819A/is unknown
- 2001-01-23 BG BG105171A patent/BG105171A/bg unknown
- 2001-01-25 ZA ZA200100743A patent/ZA200100743B/en unknown
- 2001-01-26 NO NO20010468A patent/NO20010468L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ509521A (en) | 2003-11-28 |
| NO20010468L (no) | 2001-03-27 |
| ZA200100743B (en) | 2002-05-08 |
| TR200100234T2 (tr) | 2001-06-21 |
| JP2002521452A (ja) | 2002-07-16 |
| CA2338558A1 (en) | 2000-02-10 |
| IS5819A (is) | 2001-01-19 |
| AU5148199A (en) | 2000-02-21 |
| AU766019B2 (en) | 2003-10-09 |
| BR9912466A (pt) | 2001-04-17 |
| US7053077B1 (en) | 2006-05-30 |
| HUP0102913A3 (en) | 2002-03-28 |
| EP1100509A1 (de) | 2001-05-23 |
| EA200100108A1 (ru) | 2001-12-24 |
| CN1311683A (zh) | 2001-09-05 |
| AP2001002054A0 (en) | 2001-03-31 |
| MXPA01000548A (es) | 2002-04-08 |
| BG105171A (bg) | 2001-07-31 |
| ATE292468T1 (de) | 2005-04-15 |
| PL345588A1 (en) | 2001-12-17 |
| IL141081A0 (en) | 2002-02-10 |
| HK1040192A1 (zh) | 2002-05-31 |
| EP1100509B1 (de) | 2005-04-06 |
| KR20010072082A (ko) | 2001-07-31 |
| DE19834931A1 (de) | 2000-02-24 |
| SK1292001A3 (en) | 2001-07-10 |
| JP4891479B2 (ja) | 2012-03-07 |
| HUP0102913A2 (hu) | 2002-01-28 |
| DE59911879D1 (de) | 2005-05-12 |
| EA003371B1 (ru) | 2003-04-24 |
| WO2000006175A1 (de) | 2000-02-10 |
| CO5261567A1 (es) | 2003-03-31 |
| NO20010468D0 (no) | 2001-01-26 |
| EE200100053A (et) | 2002-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR016502A1 (es) | Uso de sulfamatos estrogenos biogenicos en una terapia de reemplazo de hormonas. | |
| US5521166A (en) | Antiprogestin cyclophasic hormonal regimen | |
| KR960001371B1 (ko) | 폐경기 전의 여성용 혼합 제형 및 이를 포함하는 팩 | |
| KR960704553A (ko) | 적어도 하나의 프로게스토겐과 적어도 하나의 에스트로겐을 함유하는 대용요법용 제제(preparation for substitution therapy containing at least one progestogen and at least one estrogen) | |
| KR100365879B1 (ko) | 프로게스테론길항제및게스타겐을포함하는자궁내막증식증또는자궁평활근종치료제 | |
| JP3937240B2 (ja) | 黄体ホルモン関連の破綻出血の最小化 | |
| NL300381I2 (nl) | Estradiolvaleraat en dienogest | |
| ATE136781T1 (de) | Ovulationshemmendes mittel zur hormonalen kontrazeption | |
| Johansson et al. | New delivery systems in contraception: vaginal rings | |
| LU91065I2 (fr) | Drospirenone en combinaison avec oestradiol et leurs dérivés pharmaceutiquement acceptables (Allurene-Angeliq) | |
| ATE185072T1 (de) | Pharmazeutische präparate zur kontrazeption/hormonsubstitution mit biogener estrogenkomponente | |
| CA2267743A1 (en) | Low dose estrogen interrupted hormone replacement therapy | |
| BR0014159A (pt) | Combinação farmacêutica de etinilestradiol e drospirenona para uso como um anticoncepcional | |
| BR9709934A (pt) | Kit de terapia de reposição hormonal e/ou contraceptivo uso de unidades de dosagem diária consistindo essecialmente de um progestogênio e processo de preparação de um sistema de liberação de droga | |
| RU2004113305A (ru) | Комбинированный эстрогенный/гестагенный препарат и его применение | |
| AR049112A1 (es) | Composiciones, metodos y kit, para el tratamiento de trastorno disforico premenstrual | |
| ES2208518T3 (es) | Medio y metodo anticonceptivo hormonal. | |
| Laurikka-Routti et al. | A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry | |
| Luciano et al. | Evaluation of low-dose estrogen and progestin therapy in postmenopausal women. A double-blind, prospective study of sequential versus continuous therapy | |
| KR970706004A (ko) | 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies) | |
| RU2215540C2 (ru) | Схемы приема гестаген-антигестагена | |
| RU2000115313A (ru) | Схемы приема гестаген-анти-гестагена | |
| HUP9901474A2 (hu) | Szekvenciális ösztrogén/progeszteron-antagonista kombináció hormonhelyettesítő terápiához | |
| Borrego | How to select progestin for hormone replacement therapy | |
| MXPA01010976A (es) | Uso de antiprogestagenos en terapia combinada. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |